Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Su

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|August 20, 1986
Pharmacokinetics and effects on fibrinolytic and coagulation parameters of two doses of recombinant tissue-type plasminogen activator in healthy volunteersM Verstraete, C A Su, P Tanswell, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Lack of interaction between meloxicam and warfarin in healthy volunteersD Türck, C A Su, G Heinzel, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 26, 1976
[A "healthy" brother and sister in a family with medullary thyroid carcinoma]C A Su, H Mulder, A M Moers, et al.
British Journal of Clinical Pharmacology|August 1, 1990
Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivoT H Müller, C A Su, H Weisenberger, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Dose-dependent uricosuric effect of ambroxolB Oosterhuis, G Storm, P J Cornelissen, et al.
Arzneimittel-Forschung|March 1, 1988
Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteersE Seifried, P Tanswell, D C Rijken, et al.
Lancet (London, England)|May 3, 1975
Letter: Calcitonin release provoked by intravenous pentagastrin in medullary carcinoma of thyroidA M Moers, H Mulder, C A Su, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 22, 2014
Graft-derived CCL2 increases graft injury during antibody-mediated rejection of cardiac allograftsT Abe, C A Su, S Iida, et al.
Journal of Clinical Pharmacology|February 24, 2001
The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteersJ Stangier, C A Su, M G Hendriks, et al.
Journal of Clinical Pharmacology|February 24, 2001
Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteersJ Stangier, C A Su, M G Hendriks, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|August 20, 1986
Pharmacokinetics and effects on fibrinolytic and coagulation parameters of two doses of recombinant tissue-type plasminogen activator in healthy volunteersM Verstraete, C A Su, P Tanswell, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Lack of interaction between meloxicam and warfarin in healthy volunteersD Türck, C A Su, G Heinzel, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 26, 1976
[A "healthy" brother and sister in a family with medullary thyroid carcinoma]C A Su, H Mulder, A M Moers, et al.
British Journal of Clinical Pharmacology|August 1, 1990
Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivoT H Müller, C A Su, H Weisenberger, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Dose-dependent uricosuric effect of ambroxolB Oosterhuis, G Storm, P J Cornelissen, et al.
Arzneimittel-Forschung|March 1, 1988
Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteersE Seifried, P Tanswell, D C Rijken, et al.
Lancet (London, England)|May 3, 1975
Letter: Calcitonin release provoked by intravenous pentagastrin in medullary carcinoma of thyroidA M Moers, H Mulder, C A Su, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 22, 2014
Graft-derived CCL2 increases graft injury during antibody-mediated rejection of cardiac allograftsT Abe, C A Su, S Iida, et al.
Journal of Clinical Pharmacology|February 24, 2001
The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteersJ Stangier, C A Su, M G Hendriks, et al.
Journal of Clinical Pharmacology|February 24, 2001
Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteersJ Stangier, C A Su, M G Hendriks, et al.
Pageof 3